Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8676348rdf:typepubmed:Citationlld:pubmed
pubmed-article:8676348lifeskim:mentionsumls-concept:C0006462lld:lifeskim
pubmed-article:8676348lifeskim:mentionsumls-concept:C0379900lld:lifeskim
pubmed-article:8676348lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:8676348lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:8676348lifeskim:mentionsumls-concept:C1621296lld:lifeskim
pubmed-article:8676348lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:8676348pubmed:issue5lld:pubmed
pubmed-article:8676348pubmed:dateCreated1996-8-15lld:pubmed
pubmed-article:8676348pubmed:abstractTextA new analog of buspirone (1), i.e., 8-[4-[2-(1,2,3,4-tetrahydroisoquinolinyl)]butyl]-8-azaspiro- [4.5]decane-7,9-dione (6a), was synthesized. In was demonstrated that buspirone and its analog 6a were equipotent 5-HT(1A) ligands. Several behavioral models showed that 6a had essentially the same functional profile at 5-HT(1A) receptors as buspirone. The obtained results permit a conclusion that the basic nitrogen atom and terminal, bulky cycloimide moiety, but not the 2-pyrimidinyl group, of buspirone are directly involved in the formation of the bioactive complex with 5-Ht1A receptors.lld:pubmed
pubmed-article:8676348pubmed:languageenglld:pubmed
pubmed-article:8676348pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8676348pubmed:citationSubsetIMlld:pubmed
pubmed-article:8676348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8676348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8676348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8676348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8676348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8676348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8676348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8676348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8676348pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8676348pubmed:statusMEDLINElld:pubmed
pubmed-article:8676348pubmed:monthMarlld:pubmed
pubmed-article:8676348pubmed:issn0022-2623lld:pubmed
pubmed-article:8676348pubmed:authorpubmed-author:Tatarczy?skaE...lld:pubmed
pubmed-article:8676348pubmed:authorpubmed-author:Chojnacka-Wój...lld:pubmed
pubmed-article:8676348pubmed:authorpubmed-author:Duszy?skiJJlld:pubmed
pubmed-article:8676348pubmed:authorpubmed-author:MokroszJ LJLlld:pubmed
pubmed-article:8676348pubmed:authorpubmed-author:MokroszM JMJlld:pubmed
pubmed-article:8676348pubmed:authorpubmed-author:BojarskiA JAJlld:pubmed
pubmed-article:8676348pubmed:authorpubmed-author:Dere?-Weso?ek...lld:pubmed
pubmed-article:8676348pubmed:issnTypePrintlld:pubmed
pubmed-article:8676348pubmed:day1lld:pubmed
pubmed-article:8676348pubmed:volume39lld:pubmed
pubmed-article:8676348pubmed:ownerNLMlld:pubmed
pubmed-article:8676348pubmed:authorsCompleteYlld:pubmed
pubmed-article:8676348pubmed:pagination1125-9lld:pubmed
pubmed-article:8676348pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:meshHeadingpubmed-meshheading:8676348-...lld:pubmed
pubmed-article:8676348pubmed:year1996lld:pubmed
pubmed-article:8676348pubmed:articleTitle8-[4-[2-(1,2,3,4-Tetrahydroisoquinolinyl]butyl-8-azaspiro[4.5]decane-7,9-dione: a new 5-HT1A receptor ligand with the same activity profile as buspirone.lld:pubmed
pubmed-article:8676348pubmed:affiliationDepartment of Medicinal Chemistry, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland.lld:pubmed
pubmed-article:8676348pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8676348pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:8676348lld:chembl